![](https://cdn.benzinga.com/files/images/story/2024/07/30/Headquarters-Rahway-Site-Entrance-HI.jpeg?width=1200&height=800&fit=crop)
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual ...
On Wednesday, Merck & Co Inc MRK reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck reported adjusted EPS of $2.28 …